1-4 of 4
Keywords: Hematological malignancy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis

Subject Area:
Hematology , Oncology
Daisuke Minakata, Shin-ichiro Fujiwara, Jin Hayakawa, Hideki Nakasone, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-ichi Ochi, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Miyuki Sugimoto, Yuko Ishihara, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Tsukasa Ohmori, Yoshinobu Kanda
Journal: Acta Haematologica
Acta Haematol (2020) 143 (3): 250–259.
https://doi.org/10.1159/000501818
Published Online: 28 August 2019
.... Objectives: To compare the clinical results of the treatment of DIC with danaparoid or SPIs. Methods: We retrospectively examined 188 patients with hematological malignancy-related DIC. Results: DIC resolution rate in the danaparoid group was higher than that in the SPIs group (61.5 vs. 42.6%; p = 0.031...
View article titled, Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span>: A Retrospective Analysis
Open the PDF for Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span>: A Retrospective Analysis in another window
Journal Articles

Risk of Onset of Hematological Malignancies in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China

Subject Area:
Hematology , Oncology
Xiaoyang Li, Yu Zheng, Hongming Zhu, Xiaojing Lin, Yunxiang Zhang, Yubing Zhao, Jiong Hu, Junmin Li
Journal: Acta Haematologica
Acta Haematol (2017) 137 (4): 209–213.
https://doi.org/10.1159/000468973
Published Online: 18 May 2017
... that HBV is associated with other human cancers. However, the association between HBV and the risk of onset of hematological malignancies remains controversial. The aim of this large-scale retrospective cohort study was to evaluate the association between HBV infection and hematological malignancies...
View article titled, Risk of Onset of <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span> in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China
Open the PDF for Risk of Onset of <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span> in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China in another window
Journal Articles

A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for Hematological Malignancies

Subject Area:
Hematology , Oncology
Qing Wei, Ting Niu, Mengyao Wang, Jinrong Yang, Pengpeng Liu, Yuyao Yi
Journal: Acta Haematologica
Acta Haematol (2017) 137 (3): 132–140.
https://doi.org/10.1159/000456645
Published Online: 30 March 2017
...Qing Wei; Ting Niu; Mengyao Wang; Jinrong Yang; Pengpeng Liu; Yuyao Yi To retrospectively validate the prognostic value of the latest Chinese disseminated intravascular coagulation (DIC) scoring system (CDSS) in hematological malignancies, 260 patients with confirmed hematological malignancies...
View article titled, A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span>
Open the PDF for A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for <span class="search-highlight">Hematological</span> <span class="search-highlight">Malignancies</span> in another window
Journal Articles

Immune-Mediated Complications during Interferon Therapy in Hematological Patients

Subject Area:
Hematology , Oncology
Pia Raanani, Isaac Ben-Bassat
Journal: Acta Haematologica
Acta Haematol (2002) 107 (3): 133–144.
https://doi.org/10.1159/000057631
Published Online: 25 April 2002
...Pia Raanani; Isaac Ben-Bassat Interferon (IFN), a leukocyte-derived cytokine, has been used to treat several hematological malignancies. The most common adverse effects of IFN are flu-like symptoms. Autoimmune side effects are infrequent but may be hazardous and irreversible. These may occur...
View article titled, Immune-Mediated Complications during Interferon Therapy in Hematological Patients
Open the PDF for Immune-Mediated Complications during Interferon Therapy in Hematological Patients in another window